-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Lexaria Bioscience Corp. quarterly Nonoperating Income (Expense) history and growth rate from Q1 2024 to Q1 2025.
- Lexaria Bioscience Corp. Nonoperating Income (Expense) for the quarter ending February 28, 2025 was $34K, a 123% increase year-over-year.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)